Author

D. Koessinger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

K. Stevenson· 3 shared A. J. Chalmers· 2 shared A. Koessinger· 2 shared C. Cloix· 2 shared J. C. Norman· 2 shared L. Mitchell· 2 shared A. Chalmers· 1 shared A. L. Koessinger· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

K. Stevenson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Glioblastoma extracellular vesicles influence glial cell hyaluronic acid deposition to promote invasiveness

J. C. Norman, D. Koessinger, D. Novo, J. Birch, L. Mitchell, M. Moore, D. Zerbst, A. Chalmers, A. Koessinger, K. Stevenson, M. Nielson

This study identifies how GBM extracellular vesicles containing podocalyxin promote astrocyte hyaluronic acid deposition, enhancing GBM invasiveness.

bioRxiv · Feb 11, 2022 · PreprintCancer Biology

Increased apoptotic priming of glioblastoma enables therapeutic targeting by BH3-mimetics

A. Koessinger, D. Koessinger, K. Kinch, L. Martinez-Escardo, N. Paul, Y. Elmasry, G. Malviya, C. Cloix, K. Campbell, F. Bock, J. O'Prey, K. Stevenson, C. Nixon, M. Jackson, G. Ichim, , S. Tait

This study shows that glioblastoma (GBM) is highly sensitive to BH3-mimetics due to elevated anti-apoptotic BCL-xL and MCL-1 expression, which can be therapeutically targeted.

bioRxiv · Jun 13, 2021 · PreprintCancer Biology

Quantitative in vivo bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts

A. L. Koessinger, D. Koessinger, K. Stevenson, C. Cloix, L. Mitchell, A. J. Chalmers, J. C. Norman, S. W. Tait

This paper demonstrates the use of iRFP expression in patient-derived glioblastoma cells for non-invasive, quantitative monitoring of tumor growth in vivo.

Scientific Reports · Sep 21, 2020Peer-reviewedCancer Biology